• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

USP22 通过激活 STING 控制 III 型干扰素信号和 SARS-CoV-2 感染。

USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING.

机构信息

Institute for Experimental Cancer Research in Pediatrics, Goethe University Frankfurt, Komturstrasse 3a, 60528, Frankfurt am Main, Germany.

Department of Infectious Diseases/Molecular Virology, Medical Faculty, Center for Integrative Infectious Diseases Research (CIID), University of Heidelberg, 69120, Heidelberg, Germany.

出版信息

Cell Death Dis. 2022 Aug 6;13(8):684. doi: 10.1038/s41419-022-05124-w.

DOI:10.1038/s41419-022-05124-w
PMID:35933402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9357023/
Abstract

Pattern recognition receptors (PRRs) and interferons (IFNs) serve as essential antiviral defense against SARS-CoV-2, the causative agent of the COVID-19 pandemic. Type III IFNs (IFN-λ) exhibit cell-type specific and long-lasting functions in auto-inflammation, tumorigenesis, and antiviral defense. Here, we identify the deubiquitinating enzyme USP22 as central regulator of basal IFN-λ secretion and SARS-CoV-2 infections in human intestinal epithelial cells (hIECs). USP22-deficient hIECs strongly upregulate genes involved in IFN signaling and viral defense, including numerous IFN-stimulated genes (ISGs), with increased secretion of IFN-λ and enhanced STAT1 signaling, even in the absence of exogenous IFNs or viral infection. Interestingly, USP22 controls basal and 2'3'-cGAMP-induced STING activation and loss of STING reversed STAT activation and ISG and IFN-λ expression. Intriguingly, USP22-deficient hIECs are protected against SARS-CoV-2 infection, viral replication, and the formation of de novo infectious particles, in a STING-dependent manner. These findings reveal USP22 as central host regulator of STING and type III IFN signaling, with important implications for SARS-CoV-2 infection and antiviral defense.

摘要

模式识别受体(PRRs)和干扰素(IFNs)是对抗 SARS-CoV-2 的重要抗病毒防御机制,SARS-CoV-2 是 COVID-19 大流行的病原体。III 型干扰素(IFN-λ)在自身炎症、肿瘤发生和抗病毒防御中具有细胞类型特异性和持久功能。在这里,我们确定去泛素化酶 USP22 是人类肠道上皮细胞(hIECs)中基础 IFN-λ 分泌和 SARS-CoV-2 感染的中央调节因子。USP22 缺陷的 hIECs 强烈地上调参与 IFN 信号和病毒防御的基因,包括许多 IFN 刺激基因(ISGs),IFN-λ 的分泌增加,STAT1 信号增强,即使在没有外源性 IFN 或病毒感染的情况下也是如此。有趣的是,USP22 控制基础和 2'3'-cGAMP 诱导的 STING 激活,而 STING 的缺失逆转了 STAT 激活和 ISG 和 IFN-λ 的表达。有趣的是,USP22 缺陷的 hIECs 以 STING 依赖的方式免受 SARS-CoV-2 感染、病毒复制和新形成的感染性颗粒的影响。这些发现揭示了 USP22 是 STING 和 III 型 IFN 信号的中央宿主调节剂,对 SARS-CoV-2 感染和抗病毒防御具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54e/9357023/2786efed5f76/41419_2022_5124_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54e/9357023/78858f4925e1/41419_2022_5124_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54e/9357023/571a9fe61884/41419_2022_5124_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54e/9357023/059049d0ca01/41419_2022_5124_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54e/9357023/9fc5392362e7/41419_2022_5124_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54e/9357023/215eaee27628/41419_2022_5124_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54e/9357023/2786efed5f76/41419_2022_5124_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54e/9357023/78858f4925e1/41419_2022_5124_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54e/9357023/571a9fe61884/41419_2022_5124_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54e/9357023/059049d0ca01/41419_2022_5124_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54e/9357023/9fc5392362e7/41419_2022_5124_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54e/9357023/215eaee27628/41419_2022_5124_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54e/9357023/2786efed5f76/41419_2022_5124_Fig6_HTML.jpg

相似文献

1
USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING.USP22 通过激活 STING 控制 III 型干扰素信号和 SARS-CoV-2 感染。
Cell Death Dis. 2022 Aug 6;13(8):684. doi: 10.1038/s41419-022-05124-w.
2
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.I型、II型和III型干扰素的抗病毒活性可抵消ACE2的诱导性并限制新型冠状病毒。
mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20.
3
Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.人肠上皮细胞中 SARS-CoV-2 对 III 型干扰素的敏感性增加。
J Virol. 2022 Apr 13;96(7):e0170521. doi: 10.1128/jvi.01705-21. Epub 2022 Mar 9.
4
Inhibition of SARS-CoV-2 by type I and type III interferons.I 型和 III 型干扰素对 SARS-CoV-2 的抑制作用。
J Biol Chem. 2020 Oct 9;295(41):13958-13964. doi: 10.1074/jbc.AC120.013788. Epub 2020 Jun 25.
5
Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.Ⅰ型和Ⅲ型干扰素限制 SARS-CoV-2 感染人呼吸道上皮细胞。
J Virol. 2020 Sep 15;94(19). doi: 10.1128/JVI.00985-20.
6
Type I and III interferons are good markers to monitor COVID-19 pathophysiology.I 型和 III 型干扰素是监测 COVID-19 病理生理学的良好标志物。
Cytokine. 2023 May;165:156172. doi: 10.1016/j.cyto.2023.156172. Epub 2023 Mar 13.
7
SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy.SARS-CoV-2 ORF10 拮抗 STING 依赖性干扰素激活和自噬。
J Med Virol. 2022 Nov;94(11):5174-5188. doi: 10.1002/jmv.27965. Epub 2022 Jul 7.
8
Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells.III 型干扰素在控制 SARS-CoV-2 感染人肠上皮细胞中的关键作用。
Cell Rep. 2020 Jul 7;32(1):107863. doi: 10.1016/j.celrep.2020.107863. Epub 2020 Jun 19.
9
IFN-λ uniquely promotes CD8 T cell immunity against SARS-CoV-2 relative to type I IFN.IFN-λ 相对于 I 型 IFN ,特异性地促进 CD8 T 细胞对 SARS-CoV-2 的免疫应答。
JCI Insight. 2024 May 21;9(13):e171830. doi: 10.1172/jci.insight.171830.
10
Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.中东呼吸综合征冠状病毒核衣壳蛋白通过靶向 RIG-I 信号抑制 I 型和 III 型干扰素的诱导。
J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.00099-20.

引用本文的文献

1
Basal IFN-λ2/3 expression mediates tight junction formation in human epithelial cells.基础干扰素-λ2/3表达介导人上皮细胞紧密连接的形成。
EMBO J. 2025 Sep 1. doi: 10.1038/s44318-025-00539-5.
2
USP22 enhances atherosclerotic plaque stability and macrophage efferocytosis by stabilizing PPARγ.USP22通过稳定PPARγ来增强动脉粥样硬化斑块稳定性和巨噬细胞吞噬作用。
Commun Biol. 2025 Apr 29;8(1):678. doi: 10.1038/s42003-025-08116-6.
3
The Dual Role of cGAS-STING Signaling in COVID-19: Implications for Therapy.cGAS-STING信号通路在新冠病毒疾病中的双重作用:对治疗的启示

本文引用的文献

1
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment.严重急性呼吸综合征冠状病毒2型奥密克戎变异株病毒分离株对干扰素治疗高度敏感。
Cell Discov. 2022 May 10;8(1):42. doi: 10.1038/s41421-022-00408-z.
2
The cGAS-STING pathway drives type I IFN immunopathology in COVID-19.cGAS-STING 通路驱动 COVID-19 中的 I 型 IFN 免疫病理学。
Nature. 2022 Mar;603(7899):145-151. doi: 10.1038/s41586-022-04421-w. Epub 2022 Jan 19.
3
SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB.
Cells. 2025 Feb 28;14(5):362. doi: 10.3390/cells14050362.
4
In search of a function for human type III interferons: insights from inherited and acquired deficits.探索人类 III 型干扰素的功能:遗传性和获得性缺陷的启示。
Curr Opin Immunol. 2024 Apr;87:102427. doi: 10.1016/j.coi.2024.102427. Epub 2024 May 22.
5
Interferon lambda in respiratory viral infection: immunomodulatory functions and antiviral effects in epithelium.干扰素 lambda 在呼吸道病毒感染中的作用:在上皮细胞中的免疫调节功能和抗病毒作用。
Front Immunol. 2024 Mar 1;15:1338096. doi: 10.3389/fimmu.2024.1338096. eCollection 2024.
6
USP22 regulates APL differentiation via PML-RARα stabilization and IFN repression.USP22通过稳定PML-RARα和抑制IFN来调节急性早幼粒细胞白血病的分化。
Cell Death Discov. 2024 Mar 11;10(1):128. doi: 10.1038/s41420-024-01894-8.
7
Ubiquitin-specific proteinase 1 stabilizes PRRSV nonstructural protein Nsp1β to promote viral replication by regulating K48 ubiquitination.泛素特异性蛋白酶 1 通过调节 K48 泛素化稳定 PRRSV 非结构蛋白 Nsp1β 以促进病毒复制。
J Virol. 2024 Mar 19;98(3):e0168623. doi: 10.1128/jvi.01686-23. Epub 2024 Feb 20.
8
Usp22 Deficiency Leads to Downregulation of PD-L1 and Pathological Activation of CD8 T Cells and Causes Immunopathology in Response to Acute LCMV Infection.Usp22缺陷导致PD-L1下调以及CD8 T细胞的病理性激活,并在急性淋巴细胞性脉络丛脑膜炎病毒(LCMV)感染时引发免疫病理学变化。
Vaccines (Basel). 2023 Oct 5;11(10):1563. doi: 10.3390/vaccines11101563.
9
Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection.E3 泛素连接酶和去泛素化酶在 SARS-CoV-2 感染中的作用。
Front Cell Infect Microbiol. 2023 Jun 9;13:1217383. doi: 10.3389/fcimb.2023.1217383. eCollection 2023.
10
Progress of cGAS-STING signaling in response to SARS-CoV-2 infection.cGAS-STING 信号通路在应对 SARS-CoV-2 感染中的研究进展。
Front Immunol. 2022 Dec 7;13:1010911. doi: 10.3389/fimmu.2022.1010911. eCollection 2022.
SARS-CoV-2 感染通过 cGAS-STING 和 NF-κB 诱导促炎细胞因子反应。
Commun Biol. 2022 Jan 12;5(1):45. doi: 10.1038/s42003-021-02983-5.
4
Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1.蛋白酶切割 RNF20 可通过稳定 SREBP1 促进冠状病毒复制。
Proc Natl Acad Sci U S A. 2021 Sep 14;118(37). doi: 10.1073/pnas.2107108118.
5
Pattern recognition receptors in health and diseases.模式识别受体在健康与疾病中的作用
Signal Transduct Target Ther. 2021 Aug 4;6(1):291. doi: 10.1038/s41392-021-00687-0.
6
Pharmacological activation of STING blocks SARS-CoV-2 infection.STING 的药理学激活可阻断 SARS-CoV-2 感染。
Sci Immunol. 2021 May 18;6(59). doi: 10.1126/sciimmunol.abi9007.
7
A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection.一种二脒基苯并咪唑 STING 激动剂可预防 SARS-CoV-2 感染。
Sci Immunol. 2021 May 18;6(59). doi: 10.1126/sciimmunol.abi9002.
8
Functional landscape of SARS-CoV-2 cellular restriction.SARS-CoV-2 细胞限制的功能景观
Mol Cell. 2021 Jun 17;81(12):2656-2668.e8. doi: 10.1016/j.molcel.2021.04.008. Epub 2021 Apr 13.
9
Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut.单细胞分析揭示了 SARS-CoV-2 对人类肠道固有免疫反应的干扰。
Mol Syst Biol. 2021 Apr;17(4):e10232. doi: 10.15252/msb.202110232.
10
The cGAS-STING pathway as a therapeutic target in inflammatory diseases.cGAS-STING 通路作为炎症性疾病的治疗靶点。
Nat Rev Immunol. 2021 Sep;21(9):548-569. doi: 10.1038/s41577-021-00524-z. Epub 2021 Apr 8.